Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The dopaminergic response in multiple system atrophy.

A J Hughes1, C Colosimo, B Kleedorfer

  • 1Department of Neurology, Middlesex Hospital, London, UK.

Journal of Neurology, Neurosurgery, and Psychiatry
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-GeV Electron Acceleration in Wakefields Strongly Driven by Oversized Laser Spots.

Physical review letters·2024
Same author

The Outreach Virtual Fracture Clinic - a Pilot Report of the Initial Nine Months.

Irish medical journal·2023
Same author

National Hip Fracture Incidence - Past, Present and Future Projections.

Irish medical journal·2022
Same author

New Technologies in the Field of Orthopaedic and Spine Surgery - Navigating the Learning Curve

Irish medical journal·2021
Same author

Fixed drug eruption secondary to adalimumab.

Clinical and experimental dermatology·2021
Same author

Tape strips in dermatology research.

The British journal of dermatology·2020

Levodopa response in multiple system atrophy (MSA) is variable, with many patients developing motor complications. Delayed deterioration after drug withdrawal may be characteristic of MSA, distinguishing it from Parkinson's disease.

Area of Science:

  • Neurology
  • Neurodegenerative Diseases

Background:

  • Multiple system atrophy (MSA) is a progressive neurodegenerative disorder.
  • Levodopa is a common treatment for motor symptoms in MSA, but its efficacy and side effects can vary.

Purpose of the Study:

  • To investigate the response to levodopa in patients with pathologically confirmed multiple system atrophy (MSA).
  • To characterize levodopa-induced motor oscillations and dyskinesias in MSA.
  • To examine the effects of levodopa withdrawal on motor function in MSA patients.

Main Methods:

  • Analysis of 23 pathologically confirmed cases of MSA.
  • Assessment of initial and sustained levodopa response.
  • Administration of acute levodopa and apomorphine challenges to 11 levodopa-responsive patients.

Related Experiment Videos

  • Observation of motor oscillations, dyskinesias, and response to levodopa withdrawal.

    • Main Results:

    • Fifteen of 23 MSA cases showed initial levodopa response; eight remained partially responsive until death.
    • Motor oscillations and drug-induced dyskinesias (often facial) occurred in 11 patients.
    • Six patients experienced delayed deterioration 3-6 days after levodopa withdrawal, particularly those with no short-term motor response to acute challenges.

    Conclusions:

    • Levodopa response in MSA is often partial and associated with motor complications like dyskinesias.
    • Levodopa-induced dyskinesias without a motor response and delayed deterioration after withdrawal may be more typical of MSA than Parkinson's disease.